A stand-alone synbiotic treatment for the prevention of D-lactic acidosis in short bowel syndrome

Int Surg. 2013 Apr-Jun;98(2):110-3. doi: 10.9738/CC169.

Abstract

Synbiotics are combinations of probiotics and prebiotics that have recently been used in the context of various gastrointestinal diseases, including infectious enteritis, inflammatory bowel disease, and bowel obstruction. We encountered a patient with recurrent D-lactic acidosis who was treated successfully for long periods using synbiotics. The patient was diagnosed as having short bowel syndrome and had recurrent episodes of neurologic dysfunction due to D-lactic acidosis. In addition to fasting, the patient had been treated with antibiotics to eliminate D-lactate-producing bacteria. After the failure of antibiotic treatment, a stand-alone synbiotic treatment was started, specifically Bifidobacterium breve Yakult and Lactobacillus casei Shirota as probiotics, and galacto-oligosaccharide as a prebiotic. Serum D-lactate levels declined, and the patient has been recurrence-free for 3 years without dietary restriction. Synbiotics allowed the reduction in colonic absorption of D-lactate by both prevention of D-lactate-producing bacterial overgrowth and stimulation of intestinal motility, leading to remission of D-lactate acidosis.

Publication types

  • Case Reports

MeSH terms

  • Acidosis, Lactic / etiology
  • Acidosis, Lactic / therapy*
  • Adult
  • Bifidobacterium*
  • Humans
  • Lacticaseibacillus casei*
  • Male
  • Short Bowel Syndrome / complications*
  • Synbiotics*